Top 20 Defensive Halal Stocks 2026

When markets get choppy, defensive stocks, companies selling things people buy in any economy, help a portfolio hold its ground. For halal investors, the defensive playbook works especially well, because consumer staples and healthcare are among the most naturally Shariah-compliant sectors. This list gathers the top 20 defensive halal stocks for 2026: stable, cash-generative businesses that pass AAOIFI screening. They won't shoot the lights out, but they add ballast. Re-screen each before investing.

Table of Contents

• How these stocks were selected
• The top 20 defensive halal stocks for 2026
• A closer look at each defensive pick
• How to use this list

How these stocks were selected

We screened defensive sectors, consumer staples and healthcare, for stable revenue, low volatility, and durable demand, then applied AAOIFI-based Shariah screening. These industries are naturally rich in compliant companies because their products are permissible and many carry manageable debt. We excluded conventional utilities, which usually fail on leverage, and some heavily-indebted staples names.

Every name below was screened as compliant on AAOIFI-based methodology as of early 2026. Shariah compliance changes as company finances shift, so treat this as a research starting point, not a permanent verdict, and re-check each stock before investing.

The top 20 defensive halal stocks for 2026

Twenty stable, Shariah-screened defensive names across staples and healthcare. Tickers link to their Akinda Shariah report.

A closer look at each defensive pick

Procter & Gamble (PG) is a Dividend King behind everyday brands like Tide, Pampers, and Gillette. P&G has the pricing power and repeat demand that define a defensive stock, and it screens clean.

PepsiCo (PEP), another Dividend King, pairs its drinks business with Frito-Lay snacks, giving it resilience and steady cash flow through any economy.

Colgate-Palmolive (CL) is a global staple in oral and home care with fiercely loyal customers; Colgate is about as steady as consumer demand gets, though it carries some acquisition debt worth checking.

McCormick (MKC), the near-monopoly in spices and flavourings, benefits from sticky, low-ticket demand that people rarely cut back on, a quietly reliable compounder.

Mondelez (MDLZ), the owner of global snack brands like Oreo and Cadbury, blends defensiveness with emerging-market growth. Its acquisitions mean more debt than some peers, so it's worth confirming it still clears the AAOIFI financial screen.

Hershey (HSY), the dominant US confectioner, has Hershey's brand strength, which gives it durable demand, with swings in cocoa costs the main thing to watch.

Kenvue (KVUE) spun out of Johnson & Johnson; it is a pure-play consumer-health company behind Tylenol, Neutrogena, and Listerine, exactly the kind of everyday staple that holds up in downturns.

Costco (COST), a membership-warehouse compounder with fiercely loyal customers and recurring fee income, combines defensiveness with steady growth. It's a standout among the top halal stocks, pairing resilience with a long runway.

Monster Beverage (MNST), the energy-drink leader, runs a net-cash balance sheet and a permissible business, offering a slightly growthier profile than a typical staple while still benefiting from repeat demand.

Church & Dwight (CHD), the maker of Arm & Hammer and a stable of value brands, tends to hold up well when shoppers trade down, a classic recession-resilient mix.

Johnson & Johnson (JNJ), an AAA-rated healthcare giant diversified across pharma and medical devices, is the classic defensive anchor: low volatility, reliable, and compliant. It's a natural first name to screen on Akinda when building a defensive core.

Merck (MRK), anchored by its Keytruda oncology franchise, offers defensive pharma demand at a reasonable valuation, with its patent cliff the main long-term question.

Eli Lilly (LLY) combines defensive healthcare demand with rare growth from its obesity and diabetes drugs, though that growth comes at a richer valuation than most names here.

AbbVie (ABBV), with immunology drugs Skyrizi and Rinvoq replacing Humira, pairs steady demand with a strong dividend; it does carry notable debt, so check its financial screen.

Medtronic (MDT), the world's largest medical-device maker, serves broad, non-discretionary healthcare demand across a huge product range, giving it defensive stability.

Abbott Laboratories (ABT) diversified across devices, diagnostics, and nutrition. Abbott's spread of essential healthcare products makes it one of the steadier names in the sector.

Intuitive Surgical (ISRG), the maker of the da Vinci surgical system, is effectively debt-free and earns recurring revenue from instruments and services, a resilient, slightly growthier defensive holding.

Gilead Sciences (GILD), its fortress HIV franchise throws off dependable cash flow, and a solid dividend plus a low valuation make Gilead a defensive biotech anchor.

Stryker (SYK), a leader in orthopedics and medical technology, benefits from steady, ageing-population procedure demand and a long record of consistent growth.

Pfizer (PFE), a large, diversified pharma trading cheaply with a high dividend yield, offers defensive income, with its pipeline delivery being the key uncertainty.

How to use this list

Defensive stocks are best used as ballast, the stable core that steadies a halal portfolio while growth names provide the upside. A common approach is to build a base of these staples and healthcare names, then add halal tech and dividend stocks around them. Note that some staples carry acquisition debt, so re-screen names like Mondelez and Colgate before buying.

The single most important habit is to re-screen before you buy and each quarter after. Check any ticker on Akinda's halal stock screener, where each stock above links to its full Shariah report, or browse the top halal stocks. For the mechanics behind the screen, see how AAOIFI screening works.

Frequently asked questions

What are defensive stocks?

Defensive stocks are shares in companies whose products stay in demand regardless of the economic cycle, mainly consumer staples (food, household goods) and healthcare. They tend to have lower volatility and steadier earnings than the broad market, which is why investors turn to them for stability during downturns.

Why are healthcare and staples good for halal investors?

These sectors are naturally rich in Shariah-compliant companies because their products, medicines, medical devices, food, and household goods, are clearly permissible, and many firms carry manageable debt. That makes them reliable places to find defensive holdings that pass both the business and financial screens.

Do defensive halal stocks pay dividends?

Most do. Consumer staples and healthcare companies are known for consistent dividends, and several names here are Dividend Kings or Aristocrats with decades of increases. As with any screened company, purify the small impermissible portion of the dividend by giving it to charity.

Sources

AAOIFI Shari'ah Standard No. 21: Financial Paper (Shares and Bonds) – the two-stage business and financial screen used to assess each stock.

Fiqh Council of North America – ruling on investing in shares – confirms the permissibility of owning screened equities.

The Past, Present, and Future of Shari'ah-Compliant Equities (INCEIF journal) – academic context on Islamic equity screening.

Disclaimer

This article is for educational purposes only and is not financial or religious advice, and is not a recommendation to buy any security. Shariah compliance, prices, and financial data change over time; the lists here are AAOIFI-based snapshots from early–mid 2026. Verify current compliance and consult a qualified scholar before investing.